HomeFile

File

TAVR Durability Becomes Irrelevant after TRANSIT Outcomes

The international registry TRANSIT has shown treating degenerated transcatheter aortic valves (TAVs) with a second TAVR is...

SOLACI PERIPHERAL | 7th Clinical Case: Percutaneous Treatment for Nutcracker Syndrome

New SOLACI PERIPHERAL clinical case to keep learning among peers! Dr. Carlos Eduardo Díniz Couto shares a “Nutcracker”...

The Fellow’s Corner | 3rd Clinical Case: True Bifurcation Lesion: Which Strategy Should We Use?

Here is the third Fellow’s Corner clinical case to keep discussing and learning alongside the entire community...

Myocarditis and mRNA COVID-19 Vaccines: New Information from the CDC

According to the CDC (Center for Disease Control and Prevention), even though rare, a relationship between myocarditis...

Direct TAVR vs. Predilation: Potential Cost of a Simpler Procedure

Does simplifying TAVR involve a cost? At least for low-risk patients included in the PARTNER 3, the...

Bifurcations: A Long Return Journey

When it looked like the simplest techniques reach the best outcomes, along came the DK Crush studies....

European Consensus on Antithrombotic Management in TAVR

All the controlled randomized evidence recently published called for an updated document on antithrombotic management in transcatheter...

IVUS vs iFR for Left Main Decision Making

No decision on the coronary tree has more impact than left main intervention. This makes interventionists prone...